美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
SERPASIL-APRESOLINE	009296	002	NDA	HYDRALAZINE HYDROCHLORIDE; RESERPINE	TABLET;ORAL	50MG;0.2MG	No	No	1954/04/01	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL-APRESOLINE	009296	004	NDA	HYDRALAZINE HYDROCHLORIDE; RESERPINE	TABLET;ORAL	25MG;0.1MG	No	No	1954/04/01	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL	009434	002	NDA	RESERPINE	INJECTABLE;INJECTION	2.5MG/ML	No	No	1954/08/13	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL	009115	001	NDA	RESERPINE	TABLET;ORAL	0.1MG	No	No	1955/08/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL	009115	003	NDA	RESERPINE	TABLET;ORAL	0.25MG	No	No	1955/08/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL	009115	004	NDA	RESERPINE	TABLET;ORAL	1MG	No	No	1955/08/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL	009115	005	NDA	RESERPINE	ELIXIR;ORAL	0.2MG/4ML	No	No	1955/08/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL-ESIDRIX #1	011878	003	NDA	HYDROCHLOROTHIAZIDE; RESERPINE	TABLET;ORAL	25MG;0.1MG	No	No	1959/05/05	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL-ESIDRIX #2	011878	005	NDA	HYDROCHLOROTHIAZIDE; RESERPINE	TABLET;ORAL	50MG;0.1MG	No	No	1959/05/05	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued